Aim-To investigate whether the inflammatory indicators eosinophil cationic protein (ECP) and myeloperoxidase (MPO) in serum reflect possible changes in tidal flow volume (TFV) loops in children with and without obstructive lower airways disease. SubjecWmethoL: Blood sampling for serum ECP (Pharmacia CAP, FEIA) and MPO (Pharmacia, RIA) analysis and measurements of TFV loops (SensorMedics 2600) before and 15 minutes after inhaled nebulised salbutamol, were performed in 29 currently asymptomatic, awake children with recurrent bronchopulmonary obstruction (BPO) and 12 awake controls (mean age 12,6 and 12,8 months (n.s.) respectively). ResulB: Mean ECP was significantly higher in the sick children (18,2pg/l) than the controls (9,OpgA) and correlated (r=0.52) (p<0.001) with the magnitude of reversibility to salbutamol in TFV ratios (time/volume to reach peak expiratory flow to total expiratory time/volume). Excluding eczematous children Increased the correlation to r=0,60. MPO was higher in the sick children than in the controls (n.s) and correlated with TFV ratios (r=0.48, pc0.01). Conclusion: Indicators of airways' inflammation (ECP, MPO) were higher in children with recurrent BPO's than in the controls, and correlate with airways' reactivity as measured by TFV loops in awake small children
A 290
SURFACE ADSORPTION AND MINIMAL SURPACE TENSION OF BRONCHIAL SURFACTANT PREPARATIONS WITH AND WITHOUT EXOGENOUS SrmPACTANT I N PULMONARY DISEASES I l e a n a H a r t i n --C a r r e r a ,
Wolfgang B e r n h a r d , R a y e o n d o s K o n s t a n t i n o s , Anne A r n i n g , C h r i s t a Acevedo, H o r s t v o n der H a r d t ; D e p a r t m e n t of P e d i a t r i c P n e u r o n o l o g y , M e d i c a l S c h o o l H a n n o v e r , FRG.
Few p u b l i c a t i o n s h a v e d e s c r i b e d t h e a c t i v i t y of s u r f a ct a n t h a r v e s t e d f r o m t r a c h e o -b r o n c h i a l m a t e r i a l o f p a t ie n t s w i t h p u l m o n a r y d
i s e a s e s u s i n g a b u b b l e -s u r f a c t o m et e r . W e first d e t e r m i n e d t h e minimal s u r f a c e t e n s i o n s o f ~x o s u r f~, A l v e o f a c t R a n d dipalmitoylphosphatidylcholine / p h o s p h a t i d y l g l y c e r o l [7:3; mol/mol] (DPPC/PG), w h i c h w e r e 30.3 mN/m, 11.9 mN/m, a n d 9 . 5 mN/m, r e s p e c t i v e l y . Then t h e i n f l u e n c e of A l v e o f a c t R a n d DPPC/PG o n s u r f a c t a n t p r e p a r a t i o n s of p a t i e n t s w i t h v a r i o u s p u l m o r a r y d i s e a s e s was m e a s u r e d . S u r f a c t a n t p r e p a r a t i o n s o f p a t i e n t s w e r e p u r i (1) A Method f o r R e p r o d u c i b l e P u l s a t i n g B u b b l e S t u d i e s o n S u r f a c t a n t I s o l a t e d from T r a c h e a l A s p i r a t e s o f I n f a n t s . Raymondos K , arti in-Carrera I , B e r n h a r d W , C.
Acevedo, v o n d e r H a r d t , H ( s u b m i t t e d ) .
A 291 and total respiratory system compliance and resistance (C,, RJ in 54 previously healthy infants in acute phase of bronchiolitis and in 44 healthy control infants aged 1-12 months. PEDS and PUFF systems (Medical Associates, Hatfield, Pa, USA) were used for these measurements. Results: see The duration and degree of t h e preventative e f f e c t of a s i n g l e dose formoterol 12ug and salbutamol 400ug dry-powder against exerclseinduced asthma ( E I A ) was compared i n a randomised.doub1e-blind, placebo-controlled study. Sixteen children (10-14 yrs) w~t h E I A and a maximal f a l l i n FEVl of 38% (median, range:22-79%) were included i n the study. On each of 3 d i f f e r e n t days they inhaled e i t h e r formoterol 12ug o r salbutamol 400ug o r placebo dry-powder from an ISF device. A standardized submaximal treadmill exercise challenge t e s t was performed 3 and 12 hours a f t e r inhalation. The degree of preventatrve e f f e c t of active drug was calculated a s tOO*(EIAp -EIAa)/EIAp %, where EIAp and EIAa are the maximal median f a l l i n FEVl on a c t i v e drug and placebo days respectively. Formoterol afforded 72% (p-0.0001) preventative e f f e c t a t 3 hours and 69% (p-0.0001) a t 12 hours post inhalation compared t o 49% (p-0.0001) and 19% (ns) preventative e f f e c t when salbutamol was used. A t the f l r s t exercise t e s t there was no difference be-,tween formoterol and salbutamol (p-0.0551). while the difference became evident a t the second exercise t e s t a f t e r which formoterol was superior t o salbutamol (p-0.0011) i n degree of preventative e f f e c t against E I A . No s i d e e f f e c t s were observed. Conclusion: Formoterol l2ug dry-powder inhaled from an ISF device affords a c l i n i c a l l y relevant preventative e f f e c t against E I A f o r a duration_o.fL a t l e a s t 1 2 hours.
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BETWEEN-OBSERVER VARIATION OF A NEW SCORING SYSTEM FOR CF CHEST RADIOGRAPHS R Oosterkamp. S Robben, F Broker. C van der Starre, W Hop, J C d e Jongste. Depts of Paediatrics, Radiology and Biostat~stics, Erasmus UniversityIUniversity HospitalISophia Children's Hospital Rotterdam, and JulianaILukas Hospital. Apeldoorn, The Netherlands. Recently a new cystic fibrosis chest radiograph scoring system was Introduced (J Pediatrics 1993; 91: 488-495), consisting of a weighted assessment of 24 different Items for each chest X-ray. The authors stated that this scoring system had a good agreement between observers, and might b e useful to a s s e s s the severity of lung involvement in young CFpatients. We wanted to confirm between-observer agreement for thls complicated scoring system. At the Sophia Children's Hospital, Rotterdam, ;and the Juliana-Lukas Hospital, Apeldoorn, two experienced independent rradiologists were asked to score 70 chest radiographs of 10 cystic fibrosis patients under the a g e of 1 3 years, in random order and blinded. Results: The agreement. a s reflected by kappa coefficients of concordance, ranged between -0.04 and 1.00, but was marginal for most of the 24 items. The best 'agreement was reached for uncommon parameters, such a s atelectasis. The worst agreement was found for peribronchial thickening, nodularlbranching opacltles and bronchiectasis. We conclude that the reproducibility between highly experienced radiologists of this new scoring system was disappointing. This could b e overcome by applying more quantitative and strict cr~teria. Prolonged follow-up (to 2 years) of 28 children 3-14 years of age with bronchiectasis due to immunodeficiency and malformations treated with bacterial lysate, Broncho-Munal (BM), has shown clinical improvement in all cases compared to the controls. The study of antibody (Ab) levels to Streplococcru pnercmoniae antigens (Ag) in s e n , bronchoalveolar lavage fluid (BAL) and saliva in ELlSA with the use of capsular polysaccharide, protein Ag and C-polysaccharide as well as immunoglobulins A,M,G demonstrated no significant difference in systemic, local and specific immunity followed by BM treament in immunocompetent children. At the same time orally administered bacterial antigens caused significant increase in IgA and IgA-Ab levels in sera and secretions in some immunodeficient children. We thus conclude that beneficial clinical effect of BM would be at least partly based on activation of nonspecific defence mechanisms.
